KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Current Taxes: 2017-2020

Historic Current Taxes for Aquestive Therapeutics (AQST) over the last 4 years, with Dec 2020 value amounting to $316,000.

  • Aquestive Therapeutics' Current Taxes rose 5.33% to $316,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $316,000, marking a year-over-year increase of 5.33%. This contributed to the annual value of $316,000 for FY2020, which is 5.33% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Current Taxes of $316,000 as of FY2020, which was up 5.33% from $300,000 recorded in FY2019.
  • In the past 5 years, Aquestive Therapeutics' Current Taxes ranged from a high of $388,000 in FY2018 and a low of $300,000 during FY2019.
  • In the last 3 years, Aquestive Therapeutics' Current Taxes had a median value of $316,000 in 2020 and averaged $334,667.
  • Its Current Taxes has fluctuated over the past 5 years, first declined by 22.68% in 2019, then grew by 5.33% in 2020.
  • Aquestive Therapeutics' Current Taxes (Yearly) stood at $372,000 in 2017, then climbed by 4.30% to $388,000 in 2018, then fell by 22.68% to $300,000 in 2019, then rose by 5.33% to $316,000 in 2020.